Total number of projects: 6
As coordinator: 1
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0.2*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2014 | 0 | 1.500.000 | 1.500.000 | 1 | ||
2011 | 0 | 47.973.164 | 1.489.901 | 3 | ||
2010 | 5.887.150 | 2.000.000 | 693.128 | 1 | 1 |
Total number of partners: 956
Partner loyalty:
Frequent Partner: (> 2 projects): 237
Rare Partner: 719
Frequent / Rare Partner Ratio: 0.33
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2014-01-01 | Lipid antigens in intestinal inflammation and tumor development | IBDLIPIDS | participant | 1.500.000 | 1 |
2011-10-01 | A BLUEPRINT of Haematopoietic Epigenomes | BLUEPRINT | participant | 29.996.664 | 45 |
2011-04-01 | Microbes in Allergy and Autoimmunity Related to the Skin | MAARS | participant | 5.978.541 | 10 |
2011-01-01 | EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS | ENCCA | participant | 11.997.959 | 34 |
2010-10-01 | Clinical development of Enzyme Replacement Therapy in alpha-Mannosidosis patients using recombinant human enzyme | ALPHA-MAN | coordinator | 5.887.150 | 12 |
2010-10-01 | Sharing capacity across Europe in high-throughput sequencing technology to explore genetic variation in health and disease | GEUVADIS | participant | 2.000.000 | 17 |